A carregar...
Rad51 Degradation: Role in Oncolytic Virus—Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma
Background: Clinical success of poly(ADP-ribose) polymerase inhibitors (PARPi) has been limited to repair-deficient cancers and by resistance. Oncolytic herpes simplex viruses (oHSVs) selectively kill cancer cells, irrespective of mutation, and manipulate DNA damage responses (DDR). Here, we explore...
Na minha lista:
| Publicado no: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6059185/ https://ncbi.nlm.nih.gov/pubmed/28376211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw229 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|